1. Encorafenib: risk of tumour lysis syndrome

   Media release 09 December 2023 Pages: 1 - 1

2. Falsified Ozempic (semaglutide) and Saxenda (liraglutide)

   News item 09 December 2023 Pages: 2 - 2

3. Levetiracetam and clobazam may cause DRESS syndrome

   News item 09 December 2023 Pages: 3 - 3

4. Pro Doc Limitée recalls one lot of donepezil due to oversized tablets

   News item 09 December 2023 Pages: 4 - 4

5. Recall of larotrectinib (Vitrakvi) due to microbial contamination

   News item 09 December 2023 Pages: 5 - 5

6. Risk of T-cell malignancies after CAR T cell immunotherapy

   News item 09 December 2023 Pages: 6 - 6

7. Safety signal of pemphigoid with use of rivaroxaban

   News item 09 December 2023 Pages: 7 - 7

8. TING miconazole foot spray recalled due to benzene in the propellant

   News item 09 December 2023 Pages: 8 - 8

9. Use of dimethyl fumarate for MS not linked to Fanconi syndrome

   News item 09 December 2023 Pages: 9 - 9

10. ADHD medication: long-term risk of cardiovascular disorders

    Clinical study 09 December 2023 Pages: 10 - 10

11. ICIs increase risk of grade 3–4 AEs in patients with solid tumours

    Clinical study 09 December 2023 Pages: 11 - 11

12. Methotrexate increases risk of serious AEs in older patients with CKD

    Clinical study 09 December 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 09 December 2023 Pages: 13 - 13

14. Abdavomeran

    Case report 09 December 2023 Pages: 14 - 14

15. Acalabrutinib

    Case report 09 December 2023 Pages: 15 - 15

16. Aciclovir

    Case report 09 December 2023 Pages: 16 - 16

17. Actinium-225-PSMA-imaging-and-therapy/Lutetium-177-PSMA-imaging-and-therapy

    Case report 09 December 2023 Pages: 17 - 17

18. Ad26.COV2-S

    Case report 09 December 2023 Pages: 18 - 18

19. Ad26.COV2-S/elasomeran

    Case report 09 December 2023 Pages: 19 - 19

20. Adalimumab

    Case report 09 December 2023 Pages: 20 - 20

21. Adalimumab/methotrexate

    Case report 09 December 2023 Pages: 21 - 21

22. Adalimumab/Vedolizumab

    Case report 09 December 2023 Pages: 22 - 22

23. Adenosine

    Case report 09 December 2023 Pages: 23 - 23

24. Aducanumab/tozinameran

    Case report 09 December 2023 Pages: 24 - 24

25. Afatinib

    Case report 09 December 2023 Pages: 25 - 25

26. Afatinib

    Case report 09 December 2023 Pages: 26 - 26

27. Alcohol/chlorhexidine

    Case report 09 December 2023 Pages: 27 - 27

28. Alectinib

    Case report 09 December 2023 Pages: 28 - 28

29. Alemtuzumab

    Case report 09 December 2023 Pages: 29 - 29

30. Alitretinoin

    Case report 09 December 2023 Pages: 30 - 30

31. Allopurinol

    Case report 09 December 2023 Pages: 31 - 31

32. Allopurinol/cotrimoxazole

    Case report 09 December 2023 Pages: 32 - 32

33. Alpelisib

    Case report 09 December 2023 Pages: 33 - 33

34. Alteplase

    Case report 09 December 2023 Pages: 34 - 34

35. Amenamevir

    Case report 09 December 2023 Pages: 35 - 35

36. Amikacin/azithromycin/tigecycline

    Case report 09 December 2023 Pages: 36 - 36

37. Amiodarone

    Case report 09 December 2023 Pages: 37 - 37

38. Amiodarone

    Case report 09 December 2023 Pages: 38 - 38

39. Amiodarone

    Case report 09 December 2023 Pages: 39 - 39

40. Amoxicillin/clavulanic acid/metronidazole

    Case report 09 December 2023 Pages: 40 - 40

41. Amoxicillin/furazolidone/tetracycline

    Case report 09 December 2023 Pages: 41 - 41

42. Amphotericin B liposomal/antibiotics

    Case report 09 December 2023 Pages: 42 - 42

43. Amphotericin-B-liposomal

    Case report 09 December 2023 Pages: 43 - 43

44. Amphotericin-b-liposomal

    Case report 09 December 2023 Pages: 44 - 44

45. Amrubicin

    Case report 09 December 2023 Pages: 45 - 45

46. Anakinra and immunosuppressants

    Case report 09 December 2023 Pages: 46 - 46

47. Antiepileptic-drugs

    Case report 09 December 2023 Pages: 47 - 47

48. Antihypertensives

    Case report 09 December 2023 Pages: 48 - 48

49. Antineoplastics

    Case report 09 December 2023 Pages: 49 - 49

50. Antineoplastics

    Case report 09 December 2023 Pages: 50 - 50